Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Free radicals in biology and medicine

Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

Green, L. C., Wagner, D. A., Glogowski, J. A., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,061

Free Radicals in Biology and Medicine

Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

NADPH Oxidase: An Update

BABIOR, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,147

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722

Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity

Smith, L. M., Klaver, A. C., Coffey, M. P., Dang, L., & Loeffler, D. A. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.09.007 · Cited by 12

The Simple Geometry of Transmission and Stabilization in Closed and Open Economies [with Comments]

Giancarlo Corsetti, A., Pesenti, P., Clarida, R. H., & Frankel, J. A. (2007) · NBER International Seminar on Macroeconomics · doi:10.1086/653991 · Cited by 12

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease

Ray, B., Mahalakshmi, A. M., Tuladhar, S., Bhat, A., Srinivasan, A., Pellegrino, C., Kannan, A., Bolla, S. R., Chidambaram, S. B., & Sakharkar, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673395 · Cited by 14

The gut-brain axis in the pathogenesis of Parkinson’s disease

Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12

Microglial modulation as a mechanism behind the promotion of central nervous system well‐being by physical exercise

Jensen, S. K., & Yong, V. W. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12093 · Cited by 14

Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?

Jiang, T., & Chen, S. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1263-1 · Cited by 12

Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein

Liu, J., Shi, M. Y., Hong, Z., Zhang, J., Bradner, J. M., Quinn, T. J., Beyer, R. P., McGeer, P. L., Chen, S., & Zhang, J. (2010) · PROTEOMICS · doi:10.1002/pmic.200900745 · Cited by 12

Aβ, tau, α-synuclein, huntingtin, TDP-43, PrP and AA are members of the innate immune system: a unifying hypothesis on the etiology of AD, PD, HD, ALS, CJD and RSA as innate immunity disordersPreprint

BANDEA, C. I. (2013) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/000604 · Cited by 12

Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells

Vega-Benedetti, A. F., Porcedda, C., Ercoli, T., Fusco, G., Burgaletto, C., Pillai, R., Palmas, F., Cantone, A. F., Angius, F., Solla, P., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12554-3 · Cited by 13

Phytochemicals in Parkinson’s Disease: a Pathway to Neuroprotection and Personalized Medicine

Das, S., Rajeswari, V. D., Venkatraman, G., & Ramanathan, G. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01607-z · Cited by 12

Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease

Sulistio, Y. A., & Heese, K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/393510 · Cited by 11

Computational Strategies to Identify New Drug Candidates against Neuroinflammation

Pavan, M., Bassani, D., Bolcato, G., Bissaro, M., Sturlese, M., & Moro, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220208095122 · Cited by 11

Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders

Karaki, T., Haniu, H., Matsuda, Y., & Tsukahara, T. (2022) · Biomedicines · doi:10.3390/biomedicines10123126 · Cited by 11

Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity

Zhang, H., D’Agostino, C., Tulisiak, C. T., Thorwald, M. A., Bergkvist, L., Lindquist, A., Meyerdirk, L. K., Schulz, E., Becker, K., Steiner, J. A., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15622 · Cited by 11

The role of transcriptional control in multiple system atrophy

Chen, J., Mills, J. D., Halliday, G. M., & Janitz, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.015 · Cited by 11

Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells

Eleuteri, S., Polazzi, E., & Contestabile, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.033 · Cited by 12

Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum

Dodd, C., & Klein, B. (2009) · Toxicology and Industrial Health · doi:10.1177/0748233709102752 · Cited by 11

The PINK1-Mediated Crosstalk between Neural Cells and the Underlying Link to Parkinson’s Disease

Leites, E. P., & Morais, V. A. (2021) · Cells · doi:10.3390/cells10061395 · Cited by 12

Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review

Morowitz, J. M., Pogson, K., Roque, D., & Church, F. (2022) · Brain Sciences · doi:10.3390/brainsci12050536 · Cited by 11

Role of Glia in CNS Inflammation

Pawate, S., & Bhat, N. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-30398-7_14 · Cited by 11

Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells—Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer’s Pathology

Böröczky, C., Paszternák, A., Laufer, R., Tarnóczi, K., Sikur, N., Bagaméry, F., Szökő, É., Varga, K., & Tábi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146581 · Cited by 11

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson’s disease

Alborghetti, M., Ceccherelli, A., Caridi, M., Nicoletti, F., Battaglia, G., & Bruno, V. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01138-1 · Cited by 11

NRF2 at the crossroads of Parkinson’s disease and aging: Mechanistic insights and translational perspectives

García‐Yagüe, Á. J., Esteras, N., Dinkova‐Kostova, A. T., Rojo, A. I., Shiels, P. G., Dinnyés, A., Tamas, V., van Goor, H., & Lastres‐Becker, I. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.01.023 · Cited by 12

The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14

The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication

Li, F., Luo, Q., Guo, T., Zhou, S., Cheng, Z., Pan, H., & Tu, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561789 · Cited by 12

Targeting Metabolic Dysfunction in Parkinson’s Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection

Avilés-Olmos, I., Espinoza‐Vinces, C., Portugal, L. R., & Luquin, M. R. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01606-1 · Cited by 12

Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers

Mannini, B., Vecchi, G., Labrador‐Garrido, A., Fabre, B., Fani, G., Franco, J. M., Lilley, K. S., Pozo, D., Vendruscolo, M., Chiti, F., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00088 · Cited by 10

Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia

Wang, X., Wang, H., Yi, P., Baker, C. K., Casey, G., Xie, X., Luo, H., Cai, J., Fan, X., Soong, L., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110512 · Cited by 10

Ox-inflammasome involvement in neuroinflammation

Vallese, A., Cordone, V., Pecorelli, A., & Valacchi, G. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.010 · Cited by 13

Calcium influx: An essential process by which α-Synuclein regulates morphology of erythrocytes

Yang, Y., Shi, M. Y., Liu, X., Zhu, Q., Xu, Z., Liu, G., Feng, T., Stewart, T., & Zhang, J. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.09.009 · Cited by 10

H2S prevents peripheral immune cell invasion, increasing [Ca2+]i and excessive phagocytosis following hypoxia-ischemia injury in neonatal mice

Li, T., Chu, X., Xin, D., Ke, H., Wang, S., Liu, D., Chen, W., & Wang, Z. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111207 · Cited by 10

The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system

Kuter, K. Z., Śmiałowska, M., & Ossowska, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00340-1 · Cited by 11

On the Potential Therapeutic Roles of Taurine in Autism Spectrum Disorder

Rubio‐Casillas, A., Redwan, E. M. M. M., & Uversky, V. N. (2022) · Neuroglia · doi:10.3390/neuroglia4010001 · Cited by 10

Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease

Isenbrandt, A., Coulombe, K., Morissette, M., Bourque, M., Lamontagne‐Proulx, J., Paolo, T. D., & Soulet, D. (2023) · Pharmaceuticals · doi:10.3390/ph16020152 · Cited by 12

The association of Parkinson’s disease pathogenesis with inflammation

Saiki, S. (2014) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.54.1125 · Cited by 10

Effects of intrahippocampal NAC61–95 injections on memory in the rat and attenuation with vitamin E

Kim, E.-M., Elliot, J. J., Hobson, P., & O‘Hare, E. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.020 · Cited by 10

Biochemistry & Pharmacology: Open Access

(2020) · doi:10.35248/2167-0501 · Cited by 10

Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition

Joseph, S., Robbins, C. B., Allen, A., Haystead, A., Hemesath, A., Kundu, A., Ma, J. P., Johnson, K. G., Agrawal, R. V., Gunasan, V., et al. (2023) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264231206607 · Cited by 9

A potential mechanism clue to the periodic storm from microglia activation and progressive neuron damage induced by paraquat exposure

Shi, G., Zhang, C., Bai, X., Sun, J. P., Wang, K., Meng, Q., Li, Y., Hu, G., Hu, R., Cai, Q., et al. (2024) · Environmental Toxicology · doi:10.1002/tox.24053 · Cited by 9

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms

Lage, L., Rodriguez-Perez, A. I., Labandeira-García, J. L., & Dominguez‐Meijide, A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00544 · Cited by 9

Balancing Microglial Density and Activation in Central Nervous System Development and Disease

Wang, S., Pan, L., Sun, C., Ma, C., & Pan, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47050344 · Cited by 11

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

Liang, J., Li, R., Wong, G., & Huang, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00879-0 · Cited by 13

Metabolic and inflammatory roles of glial cells in neurodegenerative and cerebrovascular diseases

OGUNLEYE, F. A., Zhou, Y., Yan, L., Abhulimen, P. O., Xu, Y., Lai, M. K. P., Okunowo, W. O., Sethi, G., Fang, C., & Ma, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103120 · Cited by 11

Injection of α-syn-98 Aggregates Into the Brain Triggers α-Synuclein Pathology and an Inflammatory Response

Du, T., Wu, Z., Luo, H., Lu, S.-Y., & Ma, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00189 · Cited by 10

Human apolipoprotein A-I Gly26Arg stimulation of inflammatory responses via NF-kB activation: Potential roles in amyloidosis?

Ramella, N. A., Andújar, I., Rı́os, J. L., Rosu, S. A., Tricerri, M. A., & Schinella, G. R. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.08.002 · Cited by 9

Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism

Adu, T. S., & Mabandla, M. V. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00462-9 · Cited by 9

Ultrahigh-Performance Liquid Chromatography–High-Resolution Mass Spectrometry Metabolomics and Lipidomics Study of Stool from Transgenic Parkinson’s Disease Mice Following Immunotherapy

Gill, E. L., Koelmel, J. P., Meke, L. E., Yost, R. A., Garrett, T. J., Okun, M. S., Flores, C., & Vedam‐Mai, V. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00605 · Cited by 9

The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans

Pandey, M. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.902191 · Cited by 10

“Good” and “Bad” Microglia in Parkinson’s Disease: An Understanding of Homeostatic Mechanisms in Immunomodulation

Tang, Y., & Le, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_4 · Cited by 10

Dietary Phytochemicals in Neurodegenerative Disease

Jacquet, A. D. R., Tambe, M. A., & Rochet, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00018-7 · Cited by 8

Microglia and Microbiome-Gut-Brain Axis

Filho, A. M. C., Gomes, N. S., Lós, D. B., Leite, I. B., Tremblay, M., & Macêdo, D. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_17 · Cited by 8

Enhancements in Parkinson's Disease Management: Leveraging Levodopa Optimization and Surgical Breakthroughs

Sharma, R., Kour, A., & Dewangan, H. K. (2024) · Current Drug Targets · doi:10.2174/0113894501319817240919103802 · Cited by 8

IC100 blocks inflammasome activation induced by α-synuclein aggregates and ASC specks

Cyr, B. S., Vontell, R., Hadad, R., Vaccari, J. P. D. R., & Keane, R. W. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00963-8 · Cited by 11

Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity

Yang, P.-N., Chen, W., Lee, J.-W., Lin, C., Chen, Y., Lin, C., Lin, W., Yao, C., Wu, Y., Chang, K., et al. (2023) · Aging · doi:10.18632/aging.204954 · Cited by 7

Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00683-8 · Cited by 8

Alpha-synuclein and Parkinson disease

LIU, H. (2007) · Neural Regeneration Research · doi:10.1016/s1673-5374(07)60053-x · Cited by 8

Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA

Chan, H. H. N., Kumar, S. S., & Zhuo, L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.023 · Cited by 8

Distinct responses of human peripheral blood cells to different misfolded protein oligomers

Leal‐Lasarte, M., Mannini, B., Chiti, F., Vendruscolo, M., Dobson, C. M., Roodveldt, C., & Pozo, D. (2021) · Immunology · doi:10.1111/imm.13377 · Cited by 8

Electrochemical flow injection analysis of the interaction between pyrroloquinoline quinone (PQQ) and α-synuclein peptides related to Parkinson's disease

Li, S., Noroozifar, M., Zhou, J., & Kerman, K. (2021) · The Analyst · doi:10.1039/d1an00698c · Cited by 8

Cerebral Microstructural Alterations in Patients With Early Parkinson’s Disease Detected With Quantitative Magnetic Resonance Measurements

Klietz, M., Elaman, M. H., Mahmoudi, N., Nösel, P., Ahlswede, M., Wegner, F., Höglinger, G. U., Lanfermann, H., & Ding, X. Q. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.763331 · Cited by 8

Induction of neuronal damage in guinea pig brain by intratracheal infusion of 2‐chloroethyl ethyl sulfide, a mustard gas analog

Gadsden‐Gray, J., Mukherjee, S., Ogunkua, O., & Das, S. K. (2011) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20409 · Cited by 8

Genetics of Parkinson's Disease

Huang, Y. M., Chan, P., & Halliday, G. M. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50169-1 · Cited by 10

Autonomic dysfunction in early and advanced Parkinson's disease

Pursiainen, V. (2007) · Cited by 8

Human Microglia–Like Cells Differentiated from Monocytes with GM-CSF and IL-34 Show Phagocytosis of α-Synuclein Aggregates and C/EBPβ-Dependent Proinflammatory Activation

Llaves-López, A., Micoli, E., Belmonte‐Mateos, C., Aguilar, G., Alba, C. J., Marsal-Cots, A., Pulido-Salgado, M., Rabaneda‐Lombarte, N., Solà, C., Serratosa, J., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04289-z · Cited by 8

Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities

Zeng, S., Xiong, X., Long, H., Xu, Q., Yu, Y., Sun, B., Liu, C., Wang, Z., Xu, W., Zhang, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62755-1 · Cited by 7

Probable role of the hyperpolarization-activated current in the dual effects of CB1R antagonism on behaviors in a Parkinsonism mouse model

Soti, M., Ranjbar, H., Kohlmeier, K. A., Razavinasab, M., Masoumi‐Ardakani, Y., & Shabani, M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.10.015 · Cited by 7

Synaptotagmin‐11 regulates immune functions of microglia in vivo

Zhang, F., Yang, D., Li, J., Du, C., Sun, X., Li, W., Liu, F., Yang, Y., Li, Y., Fu, L., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16003 · Cited by 7

α-Synuclein Impacts on Intrinsic Neuronal Network Activity Through Reduced Levels of Cyclic AMP and Diminished Numbers of Active Presynaptic Terminals

Leite, K., Garg, P., Spitzner, F. P., Darvas, S. G., Bähr, M., Priesemann, V., & Kügler, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.868790 · Cited by 7

A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: The ROPI-PARK Study

Valldeoriola, F., Cobaleda, S., & Lahuerta, J. J. (2009) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.07.018 · Cited by 7

Early decrease in intermediate monocytes in peripheral blood is characteristic of multiple system atrophy-cerebellar type

Matsuse, D., Yamasaki, R., Maimaitijiang, G., Yamaguchi, H., Masaki, K., Isobe, N., Matsushita, T., & Kira, J. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577395 · Cited by 7

Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model

Ho, D. H., Nam, D., Jeong, S., Seo, M. K., Park, S. W., Seol, W., & Son, I. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105349 · Cited by 8

Alpha Synuclein and Parkinson’s Disease

Parihar, A., Parihar, P., Solanki, I., & Parihar, M. S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_1 · Cited by 8

Enzyme therapy of cancer, future studies.

Holcenberg, J. S. (1981) · PubMed · Cited by 7

Cell–cell communication by Endocannabinoids during Immune Surveillance of the Central Nervous System

Ullrich, O., Schneider‐Stock, R., & Zipp, F. (2006) · Springer eBooks · doi:10.1007/400_015 · Cited by 7

Malvidin-3-O-Glucoside Mitigates α-Syn and MPTP Co-Induced Oxidative Stress and Apoptosis in Human Microglial HMC3 Cells

Sood, R., Sanjay, S., Kang, S.-U., Yoon, N. Y., & Lee, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312733 · Cited by 6

Parkinson’s disease: genetics and neuroinflammatory insights

Chandel, I., Kumari, S., Bagri, K., Bhatia, A., & Deshmukh, R. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01832-9 · Cited by 6

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils

Ekmark‐Lewén, S., Aniszewska, A., Molisak, A., Gumucio, A., Lindström, V., Kahle, P. J., Nordström, E., Möller, C., Fälting, J. M., Lannfelt, L., et al. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100086 · Cited by 8

Alpha-synuclein and RNA viruses: Exploring the neuronal nexus

Gupta, A., Bohara, V. S., Banasavadi‐Siddegowda, Y., Chaudhary, N., & Kumar, S. (2024) · Virology · doi:10.1016/j.virol.2024.110141 · Cited by 6

Transcranial magneto-acoustic stimulation enhances motor function and modulates cortical excitability of motor cortex in a Parkinson's disease mouse model

Zhang, S., Wang, Q., Xu, Y., Zhang, H., Mi, J., Lu, X., Fan, R., Lv, J., & Xu, G. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115364 · Cited by 6

Disease modifying therapies for Parkinson's disease: Novel targets

Vijiaratnam, N., & Foltynie, T. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108839 · Cited by 6

Direct inhibition of microglial activation by a μ receptor selective agonist alleviates inflammatory-induced pain hypersensitivity

Wang, J., Ru, Q.-M., Ru, Q.-M., Wang, C., Li, K., Wang, C., Li, N., Zhao, J., Wood, J. N., Liu, X., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176182 · Cited by 6

In Situ Temporospatial Characterization of the Glial Response to Prion Infection

Michael, A. V., Greenlee, J. J., Harm, T. A., Moore, S. J., Zhang, M., Lind, M. S., Greenlee, M. H. W., & Smith, J. D. (2019) · Veterinary Pathology · doi:10.1177/0300985819861708 · Cited by 6

Internalization of particulate delivery systems by activated microglia influenced the therapeutic efficacy of simvastatin repurposing for neuroinflammation

Manickavasagam, D., & Oyewumi, M. O. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118690 · Cited by 6

The Treatment of Parkinson’s Disease with Sodium Oxybate

Mamelak, M. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467216666221103121135 · Cited by 6

Microglia in the Physiology and Pathology of Brain

Nagayach, A., Patro, N., & Patro, I. K. (2015) · Proceedings of the National Academy of Sciences India Section B Biological Sciences · doi:10.1007/s40011-015-0585-y · Cited by 6

Toxin-Mediated Complex I Inhibition and Parkinson’s Disease

Miranda, B. R. D., Houten, B. V., & Sanders, L. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_6 · Cited by 6

Polypeptide and Protein Aggregates with Neurotoxic Properties in Neurodegenerative Disorders: Emphasis on β-Amyloid-Induced Dysfunction of Receptor-Mediated Signal Transduction Pathways

Verdier, Y., & Penke, B. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269208 · Cited by 6

An Update on CSF Biomarkers of Parkinson’s Disease

LeWitt, P. A., Huber, B. R., & Zhang, J. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_8 · Cited by 6

Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases

Sastre, M., Katsouri, L., Birch, A. M., Renziehausen, A., Dexter, D. T., Crichton, R. R., & Ward, R. J. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch6 · Cited by 6

Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects

Barbierato, M. (2012) · Padua Research Archive (University of Padova) · Cited by 6

Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study

Wang, Y., Gao, P.-P., Wu, Z., Jiang, B., Wang, Y., He, Z., Zhao, B., Tian, X., Gao, H., Cai, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119095 · Cited by 6

Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathy

Byrne, M. D., Petramfar, P., Lee, J., & Smeyne, R. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-10705-8 · Cited by 6

The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes

Baridjavadi, Z., Mahmoudi, M., Abdollahi, N., Ebadpour, N., Mollazadeh, S., Haghmorad, D., & Esmaeili, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4109 · Cited by 5

Comparison of Alpha-Synuclein Immunoreactivity in the Hippocampus Between the Adult and Aged Beagle Dogs

Ahn, J. H., Park, J. H., Yan, B. C., Lee, J., Choi, J. H., Lee, C. H., Yoo, K., Hwang, I. K., Kim, J. S., Shin, H., et al. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9873-8 · Cited by 5

Current Understanding of the Glial Response to Disorders of the Aging CNS

Barker, R. A., & Cicchetti, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00095 · Cited by 5

Behavioural deterioration induced by intrahippocampal NAC61–95 injections and attenuation with ibuprofen

O‘Hare, E., Elliott, J. J., Hobson, P., Spanswick, D. C., & Kim, E. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.027 · Cited by 5

Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease

Cebrián, C., & Sulzer, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00008-0 · Cited by 7

Polyphenol Supplementation Reverses Age-Related Changes in Microglial Signaling Cascades

Jalloh, A., Flowers, A., Hudson, C., Chaput, D., Guergues, J., Stevens, S. M., & Bickford, P. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126373 · Cited by 5

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response

Ajjuri, R. R., & O’Donnell, J. M. (2013) · Journal of Visualized Experiments · doi:10.3791/50892-v · Cited by 5

The FASEB Journal • Research Communication Aggregated -synuclein activates microglia: a process leading to disease progression in Parkinson’s disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., & Zhang, J. (2016)

Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation

Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156

Extracellular α-synuclein – a possible initiator of inflammation in Parkinson's disease

Ren, W., Zeng-min, T., Yin, F., Sun, J.-Z., & Zhang, J. (2016) · Die Pharmazie · doi:10.31083/ph.2016.5070 · Cited by 3

Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease

Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P. S., Cerny, R. L., Gelman, B. B., Thomas, M. P., Mosley, R. L., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 247

doi: 10.3389/fnins.2011.00080

Béraud, D., Twomey, M. A., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., Maguire-zeiss, K. A., Stanilova, S. A., et al. (2011)